scholarly journals [Corrigendum] Aurora kinase inhibitors:�Potential molecular-targeted drugs for gynecologic malignant tumors (Review)

2019 ◽  
Author(s):  
Kiyoko Umene ◽  
Kouji Banno ◽  
Iori Kisu ◽  
Megumi Yanokura ◽  
Yuya Nogami ◽  
...  
2013 ◽  
Vol 1 (3) ◽  
pp. 335-340 ◽  
Author(s):  
KIYOKO UMENE ◽  
KOUJI BANNO ◽  
IORI KISU ◽  
MEGUMI YANOKURA ◽  
YUYA NOGAMI ◽  
...  

2006 ◽  
Vol 8 (2) ◽  
pp. 93-98 ◽  
Author(s):  
Oliver Gautschi ◽  
Philip C. Mack ◽  
Angela M. Davies ◽  
Primo N. Lara ◽  
David R. Gandara

2018 ◽  
Vol 18 (3) ◽  
pp. 199-213
Author(s):  
Guangying Qi ◽  
Jing Liu ◽  
Sisi Mi ◽  
Takaaki Tsunematsu ◽  
Shengjian Jin ◽  
...  

Aurora kinases are a group of serine/threonine kinases responsible for the regulation of mitosis. In recent years, with the increase in Aurora kinase-related research, the important role of Aurora kinases in tumorigenesis has been gradually recognized. Aurora kinases have been regarded as a new target for cancer therapy, resulting in the development of Aurora kinase inhibitors. The study and application of these small-molecule inhibitors, especially in combination with chemotherapy drugs, represent a new direction in cancer treatment. This paper reviews studies on Aurora kinases from recent years, including studies of their biological function, their relationship with tumor progression, and their inhibitors.


2020 ◽  
Vol 30 (3) ◽  
pp. 126885 ◽  
Author(s):  
Yu Xu ◽  
Shu-Yi Hao ◽  
Xiu-Juan Zhang ◽  
Wen-Bo Li ◽  
Xue-Peng Qiao ◽  
...  

2007 ◽  
pp. 157-175
Author(s):  
Mitesh Borad ◽  
Steven Warner ◽  
Daniel Von Hoff

2008 ◽  
Vol 3 (3) ◽  
pp. 162-177 ◽  
Author(s):  
Xia Tao ◽  
Hye Chon ◽  
Siqing Fu ◽  
John Kavanagh ◽  
Wei Hu

2010 ◽  
Vol 20 (8) ◽  
pp. 2443-2447 ◽  
Author(s):  
Stéphanie Blanchard ◽  
Anthony D. William ◽  
Angeline C.-H. Lee ◽  
Anders Poulsen ◽  
Ee Ling Teo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document